NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

NewsGuard 100/100 Score

Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.

NPS, established in 2002 and headquartered in Scottsdale, Arizona, is an alternative sampling service provider specializing in innovative promotional programs for pharmaceutical manufacturers. NPS's alternative sampling programs reduce the labor and distribution costs associated with providing branded drug samples to doctors and their patients. NPS works with its pharmaceutical clients to create custom brand enhancement programs designed to attract new clients and increase the loyalty of existing patients.

According to the selecting authorities, the decision to choose NPS to provide their Pharmaceutical Marketing solutions was based on a combination of the demonstrated success NPS has delivered previously; an intense commitment to client satisfaction; and a compelling financial proposal. Rick Randall, President of NPS, stated, "We're delighted to have been chosen to provide marketing solutions for our Pharmaceutical Manufacturing partners and look forward to creating and delivering unique and highly effective campaigns that will enhance their brand performance."

Source:

National Patient Services - A Triplefin Company

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights global fertility decline and its implications for the future